Navigation Links
3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
Date:11/8/2007

ng collaboration.

"Food safety remains an important growth platform for 3M," said Chuck Kummeth, vice president and general manager, 3M Medical Division. "But we have chosen to focus on opportunities other than molecular food testing that are more economically attractive. This decision does not affect our separate partnership with Gen-Probe to develop nucleic acid tests to detect dangerous healthcare-associated infections such as methicillin-resistant Staphylococcus aureus (MRSA)."

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning management's objectives and future growth are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. Some of the risks, uncertainties and
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. A new molecular zip code, and a new drug target for Huntingtons disease
2. New knock-out gene model provides molecular clues to breast cancer
3. Molecular probe paints cancer cells in living animals, Stanford researchers find
4. Story ideas from molecular & cellular proteomics
5. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
8. Molecular profiling can accurately predict survival in colon cancer patients
9. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
10. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
11. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2008)...Paul Parker is pleased to announce enhanced patien...aging for http://www.parkercenter.net/plastic_sur...New Jersey]. Paramus plastic surgeon, Dr. Paul M....on to itself but rather complement other facial fe...ce, gender and ethnicity." , ...
(Date:10/8/2008)...test-kit.com is a new site aimed at allowing peopl...fort and privacy of their own home, an important c...ped that through home tests more people will be te..., New York (PRWEB) October...g more used to getting instant results from a vari...
(Date:10/8/2008)... Information Association (DIA) will host the 6th C...rio, Canada) to discuss a number of important issu...ry, health academia, and the health care system. ...ber 8, 2008 -- The http://www.diahome.org/ [Drug I.../www.diahome.org/diahome/FlagshipMeetings/home.asp...
(Date:10/8/2008)...rateAnswers™ support program provides client...ww.appointment-plus.com [online scheduling softwa...le, AZ (PRWEB) October 8, 2008 -- Appointment-Plus...ware, continues to expand its software client base...tware as a service" providers are seeking way...
Breaking Medicine News(10 mins):Health News:New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey 2Health News:New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey 3Health News:New Jersey Rhinoplasty Patients Can Now See the Future at The Parker Center for Plastic Surgery New Jersey 4Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Appointment-Plus Continues Innovation With Technical Support Program 2
... in Romania have confirmed the presence of new H5N...ird flu infection in Ostrov // (near the Bulgarian...fected by bird flu. Laboratory examination done o...n confirmed to be positive for bird flu infection....
...hat complex regional pain syndrome is a neurologic...cting small fibers which has the ability to sense ...atic limb pain and other disturbances that continu...ealed. But the causes of the symptoms of the syndr...
...rchers say that they have formulated a combination... It was believed for a long time that new borns di...laid to rest by stringent research. The problem wa...g the basic constitution of infants. Principal i...
... a lesser risk of Parkinson’s, according to novel ...urosurgery and Psychiatry. // The research team, ...06 Parkinson’s patients and 106 healthy people, be...roups’ responded to questions that sought to throw...
Other Medicine News:
(Date:10/6/2008)...he American College of Nutrition ...Newswire/ -- New research on the benefits of,probi... American College of,Nutrition (ACN) Annual Meetin...otics in Health and Disease." Scientific experts i...iscussed the potential uses for,probiotics in chil...
(Date:10/6/2008)...wire-FirstCall/ -- Genaera,Corporation (Nasdaq: G...clinical trial of trodusquemine (MSI-1436), Genaer...2 diabetes and obesity. MSI-1436 is a novel,inhibi...ntrols the function,of both the leptin and insulin...te. In the study, MSI-1436 was found to be well-to...
(Date:10/6/2008)...for 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNewswi...N) announced today that it has completed the plann...uble-blind, placebo-controlled IMPACT,(IMmunothera...wn as D9902B),clinical trial designed to assess th...e cellular immunotherapy PROVENGE(R) (sipuleucel-T...
(Date:10/6/2008).../ -- Dendreon Corporation (Nasdaq:,DNDN) will host...at 9:00 AM,ET (6:00 AM PT) to review the outcome o...y for Prostate AdenoCarcinoma Treatment, also know...ucel-T), the Company,s investigational,active cell...rostate,cancer., Those interested may access t...
Breaking Medicine Technology:'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor 1220 1Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor 1220 2 242 7 million awarded for metastatic colon cancer research 771 1 242 7 million awarded for metastatic colon cancer research 771 2 242 7 million awarded for metastatic colon cancer research 771 3Scientists Spot Eyes Motion Sensors 3505 1Scientists Spot Eyes Motion Sensors 3505 2National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts 3500 1National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts 3500 2
...ab A/S (CSE: GEN),announced today that the results...rade;) in patients with rheumatoid,arthritis (RA) ...07,Annual European Congress of Rheumatology (EULAR...esults from the double-blind,placebo controlled P...m the previous interim analysis, will be described...
...2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX) ...ongoing data analysis of the recently-completed,ra...II clinical,trial of PROCHIEVE(R) 8% (progesterone... with a previous preterm birth earlier than,35 wee...CHIEVE 8%,in delaying cervical shortening. A short...
Other Medicine Technology:Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 2Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 3
Inside and out, the Achieva is designed to unleash a new era, in which the clinical capabilities of MR will further expand.
The Akbarnia PDR Instruments are specially designed to help surgeons negotiate in and around vertebral structures in posteriolateral decompression and reconstruction procedures. The instruments featu
A general instrument set consisting of 38 cobbs, osteotomes, elevators, and chisels with utility in the spine. The instruments extra (15) length provides a positive grip. These instruments, best appl
Autologous growth factors (AGF) technology. Using the patient's own blood, the AGF gel delivers a cocktail of naturally occurring growth factors and proteins in high concentrations that may enhance t
Medicine Products: